The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism by N. Clere et al.
The human papillomavirus type 18 E6 oncoprotein induces
Vascular Endothelial Growth Factor 121 (VEGF121)
transcription from the promoter through a p53-independent
mechanism
Submitted by Nicolas Clere on Tue, 07/21/2015 - 18:48
Titre
The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial
Growth Factor 121 (VEGF121) transcription from the promoter through a p53-
independent mechanism
Type de
publication Article de revue
Auteur
Clere, Nicolas [1], Bermont, Laurent [2], Fauconnet, Sylvie [3], Lascombe, Isabelle













revue Experimental Cell Research
ISSN 0014-4827
Mots-clés Angiogenesis [9], Cervical cancer [10], E6 oncoprotein [11], HPV18 [12], VEGF [13]
Résumé en
anglais
Altered angiogenic response is associated with high-grade cervical dysplasia and
with invasive squamous carcinoma of the cervix. Vascular Endothelial Growth Factor
(VEGF) is one of the most potent inducers of angiogenesis and is up-regulated in
carcinoma of the cervix. Infection by high-risk human papillomavirus and persistent
expression of viral oncogene E6 are etiologically linked to the development of
cervical cancer. E6 is able to immortalize cells and induce malignant transformation
by inactivating p53. In cervical cancer, regulation of VEGF expression is poorly
described. Thus, we investigated whether E6 oncoprotein could regulate VEGF
expression in HPV18-positive cervical cancer-derived HeLa cells harboring a wild-
type p53. The alternative splicing of vegf mRNA renders three major isoforms of
121, 165 and 189 amino-acids in humans. We have designed isoform specific real
time QRT-PCR assays to quantitate vegf transcripts and VEGF121 was the
predominant isoform. Silencing HPV18 E6 mRNA with specific siRNA reduced
VEGF121 expression by at least 50% whereas silencing of p53 did not alter its
expression. Treatment with cycloheximide did not inhibit E6-induced VEGF121
expression. Collectively, these results suggest that HPV18 E6 oncoprotein
contributes to tumor angiogenesis by inducing VEGF transcription from the
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